title: Site-specific protein labeling in the pharmaceutical industry: experiences from novartis drug discovery.
abstract: Chemically modified proteins play an important role in several fields of pharmaceutical R&D, starting from various activities in drug discovery all the way down to biopharmaceuticals with improved properties such as antibody-drug conjugates. In the first part of the present chapter the significance and use of labeled proteins in biophysical methods, biochemical and cellular assays, in vivo imaging, and biopharmaceuticals is reviewed in general. In this context, the most relevant methods for site-specific modification of proteins and their application are also described. In the second part of the chapter, in-house (Novartis) results and experience with different techniques for selective protein labeling are discussed, with a focus on chemical or enzymatic (Avi-tag) biotinylation of proteins and their application in biophysical and biochemical assays. It can be concluded that while modern methods of site-specific protein labeling offer new possibilities for pharmaceutical R&D, classical methods are still the mainstay mainly due to being well established. However, site-specific protein labeling is expected to increase in importance, in particular for antibody-drug conjugates and other chemically modified biopharmaceuticals.
authors.affiliation: Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research, Novartis Campus, 4056, Basel, Switzerland, lukas.leder@novartis.com.
authors.forename: Lukas
authors.initials: L
authors.lastname: Leder
mesh_terms: D000818:Animals; D019921:Biotinylation; D055808:Drug Discovery; D004345:Drug Industry; D006801:Humans; D025941:Protein Interaction Mapping; D011506:Proteins / Q000737:chemistry*; D013194:Staining and Labeling; D020349:Surface Plasmon Resonance
chemical_list: D011506:Proteins